Drug Profile
Lidocaine hydrochloride - AYUMI Pharma
Alternative Names: ORA injectionLatest Information Update: 20 Jan 2022
Price :
$50
*
At a glance
- Originator Showa Yakuhin Kako
- Developer AYUMI Pharma
- Class Acetanilides; Class Ib antiarrhythmics; Local anaesthetics; Non-opioid analgesics; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaesthesia
Most Recent Events
- 12 Feb 2019 Chemical structure information added
- 13 Oct 2015 Launched for Anaesthesia in Japan (Topical, Injection) before October 2015
- 12 Oct 2015 Registered for Anaesthesia in Japan (Topical, Injection) before October 2015